Clinical trialNCT02277613TerminatedPhase 2Interventional

A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction

SponsorHealios K.K.Enrollment34Heart AttackNSTEMI

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a double-blind, sham-controlled clinical study to evaluate the safety and feasibility of AMI MultiStem therapy in subjects who have had a heart attack (Non-ST elevation MI).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Marc Penn, MD
Summa Health System
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Birmingham, Alabama, United States
Facility name not stated
Huntsville, Alabama, United States
Facility name not stated
Los Angeles, California, United States
Facility name not stated
Clearwater, Florida, United States
Facility name not stated
Gainesville, Florida, United States
Facility name not stated
Tampa, Florida, United States
Facility name not stated
Detroit, Michigan, United States
Facility name not stated
Akron, Ohio, United States
Facility name not stated
Pittsburgh, Pennsylvania, United States
Facility name not stated
Salt Lake City, Utah, United States
Facility name not stated
Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AMI MultiStem cells

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2015
Primary completion: 30 Jun 2019
Completion: 31 Jan 2020
Last update posted: 22 Jul 2021
Registered enrollment: 34
Registry id: NCT02277613

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.